Combining ERBB family and MET inhibitors is an effective therapeutic strategy in cutaneous malignant melanoma independent of BRAF/NRAS mutation status
| Image |  |
|---|---|
| Description | scientific article published on 10 September 2019 |
| Author/s |
author: Rodolfo Franco-Márquez Ishani Das Suzanne Egyhazi Brage |
| Publication date | September 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |